BiovaxID dasiprotimut-T regulatory update

Biovest said EMA accepted for review an MAA for BiovaxID to treat follicular non-Hodgkin's lymphoma (NHL). BiovaxID is an autologous vaccine containing tumor-specific idiotype proteins from an individ...